Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Sesotho dictionary to be published
2008-04-15

 
Mr Motsamai Motsapi,  editor-in-chief.

A comprehensive bilingual Sesotho dictionary will be published in the 2008/2009 financial year, thanks to the efforts of the Sesiu sa Sesotho National Lexicography Unit hosted by the University of the Free State (UFS). ”Sesiu” is a Sesotho word meaning ”a reservoir for storing grains”.

According to the Editor-in-Chief of the Sesiu sa Sesotho National Lexicography Unit, Mr Motsamai Motsapi, the unit intends to continuously develop and modernize the Sesotho language so that its speakers are empowered to express themselves through Sesotho without any impediments, in all spheres of life.

The unit is one of the 11 nationally established Pan South African Language Board (PanSALB) structures representing South Africa’s 11 official languages.

Their main objective is to preserve and record the various indigenous languages by compiling user-friendly, comprehensive monolingual dictionaries and other lexicographic products, and to develop and promote these languages in all spheres of life.

The Minister of Arts and Culture, Dr Pallo Jordan, has lamented the fact that it is virtually impossible to find a bookstore in any of the country’s shopping malls that distributes literature in the indigenous African languages.

The minister said the capacity to both write and read in one’s home language gives real meaning to freedom of expression.

Therefore the publication of this Sesotho dictionary should be seen in the context of the development of the indigenous languages, as encapsulated in both the minister’s vision and that of the Sesiu sa Sesotho National Lexicography Unit.

The pending publication of this dictionary is the culmination of years of hard work invested in this project by the Sesiu sa Sesotho National Lexicography Unit.

“I believe that slowly but surely we have made some strides, as we have produced a Sesotho translation dictionary draft in 2006 covering letters A to Z. We have also built a considerable Sesotho corpus. But we still have a mammoth task ahead of us, because the work of compiling a dictionary does not end”, said Mr Motsapi.

“All Sesotho speakers should be involved, as the language belongs to the speech communities, and not to certain individuals”, he added.

He said given the reality that the UFS is situated in a predominantly Sesotho-speaking province and is part of its general community, it will always benefit the university to be part of the efforts of the South African nation to address the past by ensuring the development of the Sesotho language.

The unit is located in the African Languages Department of the Faculty of the Humanities at the UFS, and collaborates closely with the Language Research and Development Centre (LRDC) at the UFS to further the development of the Sesotho language. It is funded by PanSALB.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
15 April 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept